Hemagen Diagnostics, Inc. (HMGN)

0.0000 0.0000 (0.00%) At close: 02:25PM EDT

Hemagen Diagnostics, Inc.

9033 Red Branch Road
Columbia, MD 21045
United States
443-367-5500
https://www.hemagen.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 15

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. William P. Hales	Executive Chairman, CEO & President	192.03k	N/A	1962
Mr. M. Robert Campbell	CFO & COO	N/A	N/A	1970

Amounts are as of December 31, 2005 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.

Corporate Governance

Hemagen Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.